Clinical factors affecting endometrial receptiveness in oocyte donation cycles

Fertility and Sterility

Volumn 89, Issue 3, 2008, Pages 491-501

  Soares, Sérgio Reis ^a   Garcia Velasco, Juan Antonio ^b   Fernandez, Manuel ^b   Bosch, Ernesto ^b   Remohí, José ^b   Pellicer, Antonio ^b,c   Simón, Carlos ^b  

^a IVI Lisboa   (Portugal)

^b UNIVERSITY OF VALENCIA   (Spain)

^c HOSPITAL UNIVERSITARIO DR PESET   (Spain)

Author keywords

adenomyosis; age; body mass index; endometrial priming; Endometrial receptiveness; endometriosis; hydrosalpinx; oocyte donation; tobacco consumption

Indexed keywords

DOXYCYCLINE; ESTRADIOL; ESTRADIOL VALERATE; ESTROGEN; GONADORELIN DERIVATIVE; PROGESTERONE;

ADENOMYOSIS; BODY MASS; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG DOSE INCREASE; EMBRYO TRANSFER; ENDOMETRIOSIS; ENDOMETRIUM; FEMALE INFERTILITY; FERTILIZATION IN VITRO; GENE EXPRESSION; HUMAN; HYDROSALPINX; OOCYTE DONATION; OUTCOME ASSESSMENT; PATIENT INFORMATION; PREGNANCY RATE; PRIORITY JOURNAL; REVIEW; SMOKING; SMOKING HABIT;

AGE FACTORS; BODY MASS INDEX; EMBRYO IMPLANTATION; ENDOMETRIOSIS; ENDOMETRIUM; FALLOPIAN TUBE DISEASES; FEMALE; FERTILITY AGENTS, FEMALE; HUMANS; OOCYTE DONATION; PREGNANCY; PREGNANCY OUTCOME; SMOKING;

EID: 40249093051     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.01.080     Document Type: Review

References (105)

1. Domínguez F., Yañez-Mó M., Sánchez-Madrid F., and Simón C. Embryonic implantation and leukocyte transendothelial migration. Different processes with similar players?. FASEB J 19 (2005) 1056-1060
2. Simón C., Domínguez F., Valbuena D., and Pellicer A. The role of estrogen in uterine receptivity and blastocyst implantation. Trends Endocrinol Metab 14 (2003) 197-199
3. Horcajadas J.A., Riesewijk A., Dominguez F., Cervero A., Pellicer A., and Simón C. Determinants of endometrial receptivity. Ann N Y Acad Sci 1034 (2004) 166-175
4. Yaron Y., Ochshorn Y., Amit A., Kogosowski A., Yovel I., and Lessing J.B. Oocyte donation in Israel: a study of 1001 initiated treatment cycles. Hum Reprod 13 (1998) 1819-1824
5. Moomjy M., Cholst I., Mangieri R., and Rosenwaks Z. Oocyte donation: insights into implantation. Fertil Steril 71 (1999) 15-21
6. Legro R.S., Wong I.L., Paulson R.J., Lobo R.A., and Sauer M.V. Recipient's age does not adversely affect pregnancy outcome after oocyte donation. Am J Obstet Gynecol 172 (1995) 96-100
7. Paulson R.J., Hatch I.E., Lobo R.A., and Sauer M.V. Cumulative conception and live birth rates after oocyte donation: implications regarding endometrial receptivity. Hum Reprod 12 (1997) 835-839
8. Noyes N., Hampton B.S., Berkeley A., Licciardi F., Grifo J., and Krey L. Factors useful in predicting the success of oocyte donation: a 3-year retrospective analysis. Fertil Steril 76 (2001) 92-97
9. Cano F., Simón C., Remohí J., and Pellicer A. Effect of aging on the female reproductive system: evidence for a role of uterine senescence in the decline in female fecundity. Fertil Steril 64 (1995) 584-589
10. Toner J.P., Grainger D.A., and Frazier L.M. Clinical outcomes among recipients of donated eggs: an analysis of the U.S. national experience, 1996-1998. Fertil Steril 78 (2002) 1038-1045
11. Soares S.R., Troncoso C., Bosch E., Serra V., Simon C., Remohí J., et al. Age and uterine receptiveness: predicting the outcome of oocyte donation cycles. J Clin Endocrinol Metab 90 (2005) 4399-4404
12. Habara T., Nakatsuka M., Konishi H., Asagiri K., Noguchi S., and Kudo T. Elevated blood flow resistance in uterine arteries of women with unexplained recurrent pregnancy loss. Hum Reprod 17 (2002) 190-194
13. Fedorcsak P., Dale P.O., Storeng R., Tanbo T., and Abyholm T. The impact of obesity and insulin resistance on the outcome of IVF or ICSI in women with polycystic ovarian syndrome. Hum Reprod 16 (2001) 1086-1091
14. Nichols J.E., Crane M.M., Higdon H.L., Miller P.B., and Boone W.R. Extremes of body mass index reduce in vitro fertilization pregnancy rates. Fertil Steril 79 (2003) 645-647
15. Fedorcsak P., Dale P.O., Storeng R., Ertzeid G., Bjercke S., Oldereid N., et al. Impact of overweight and underweight on assisted reproduction treatment. Hum Reprod 19 (2004) 2523-2528
16. Van Swieten E.C., van der Leeuw-Harmsen L., Badings E.A., and van der Linden P.J. Obesity and clomiphene challenge test as predictors of outcome of in vitro fertilization and intracytoplasmic sperm injection. Gynecol Obstet Invest 59 (2005) 220-224
17. Wattanakumtornkul S., Damario M.A., Stevens Hall S.A., Thornhill A.R., and Tummon I.S. Body mass index and uterine receptivity in the oocyte donation model. Fertil Steril 80 (2003) 336-340
18. Styne-Gross A., Elkind-Hirsch K., and Scott Jr. R.T. Obesity does not impact implantation rates or pregnancy outcome in women attempting conception through oocyte donation. Fertil Steril 83 (2005) 1629-1634
19. Bellver J., Rossal L.P., Bosch E., Zúñiga A., Corona J.T., Meléndez F., et al. Obesity and the risk of spontaneous abortion after oocyte donation. Fertil Steril 79 (2003) 1136-1140
20. Bellver J., Melo M.A., Bosch E., Serra V., Remohí J., and Pellicer A. Obesity and poor reproductive outcome: the potential role of the endometrium. Fertil Steril 88 (2007) 446-451
21. Kodaman P.H., and Taylor H.S. Hormonal regulation of implantation. Obstet Gynecol Clin North Am 31 (2004) 745-766
22. Cervero A., Horcajadas J.A., Dominguez F., Pellicer A., and Simón C. Leptin system in embryo development and implantation: a protein in search of a function. Reprod Biomed Online 10 (2005) 217-223
23. Garcia-Velasco J.A., Isaza V., Caligara C., Pellicer A., Remohí J., and Simón C. Factors that determine discordant outcome from shared oocytes. Fertil Steril 80 (2003) 54-60
24. Shapiro H., Cowell C., and Casper R.F. The use of vaginal ultrasound for monitoring endometrial preparation in a donor oocyte program. Fertil Steril 59 (1993) 1055-1058
25. Abdalla H.I., Brooks A.A., Johnson M.R., Kirkland A., Thomas A., and Studd J.W. Endometrial thickness: a predictor of implantation in ovum recipients?. Hum Reprod 9 (1994) 363-365
26. Borini A., Bianchi L., Violini F., Maccolini A., Cattoli M., and Flamigni C. Oocyte donation program: pregnancy and implantation rates in women of different ages sharing oocytes from single donor. Fertil Steril 65 (1996) 94-97
27. Remohí J., Ardiles G., García-Velasco J.A., Gaitan P., Simón C., and Pellicer A. Endometrial thickness and serum estradiol concentrations as predictors of outcome in oocyte donation. Hum Reprod 12 (1997) 2271-2276
28. Coulam C.B., Bustillo M., Soenksen D.M., and Britten S. Ultrasonographic predictors of implantation after assisted reproduction. Fertil Steril 62 (1994) 1004-1010
29. Lutjen P., Trounson A., Leeton J., Findlay J., Wood C., and Renou P. The establishment and maintenance of pregnancy using in vitro fertilization and embryo donation in a patient with primary ovarian failure. Nature 307 (1984) 174-175
30. Remohí J., Gallardo E., Guanes P.P., Simón C., and Pellicer A. Donor-recipient synchronization and the use of gonadotrophin-releasing hormone agonists to avoid the premature luteinizing hormone surge in oocyte donation. Hum Reprod 10 Suppl 2 (1995) 84-90
31. Michalas S., Loutradis D., Drakakis P., Kallianidis K., Milingos S., Deligeoroglou E., et al. A flexible protocol for the induction of recipient endometrial cycles in an oocyte donation programme. Hum Reprod 11 (1996) 1063-1066
32. Yaron Y., Amit A., Mani A., Yovel I., Kogosowski A., Peyser M.R., et al. Uterine preparation with estrogen for oocyte donation: assessing the effect of treatment duration on pregnancy rates. Fertil Steril 63 (1995) 1284-1286
33. Younis J.S., Mordel N., Lewin A., Simon A., Schenker J.G., and Laufer N. Artificial endometrial preparation for oocyte donation: the effect of estrogen stimulation on clinical outcome. J Assist Reprod Genet (1992) 2222-2229
34. Remohí J., Gutiérrez A., Cano F., Ruiz A., Simón C., and Pellicer A. Long estradiol replacement in an oocyte donation programme. Hum Reprod 10 (1995) 1387-1391
35. Borini A., Del Prato L., Bianchi L., Violini F., Cattoli M., and Flamigni C. Effect of duration of estradiol replacement on the outcome of oocyte donation. J Assist Reprod Genet 18 (2001) 185-190
36. Andersen A.N., Gianaroli L., Felberbaum R., de Mouzon J., and Nygren K.G. The European IVF-monitoring programme (EIM): European Society of Human Reproduction and Embryology (ESHRE). Assisted reproductive technology in Europe, 2001. Results generated from European registers by ESHRE. Hum Reprod 20 (2005) 1158-1176
37. Younis J.S., Simon A., and Laufer N. Endometrial preparation: lessons from oocyte donation. Fertil Steril 66 (1996) 873-884
38. Devroey P., and Pados G. Preparation of endometrium for egg donation. Hum Reprod Update 4 (1998) 856-861
39. Nikas G., and Aghajanova L. Endometrial pinopodes: some more understanding on human implantation?. Reprod Biomed Online 4 Suppl 3 (2002) 18-23
40. García-Velasco J.A., Nikas G., Remohí J., Pellicer A., and Simón C. Endometrial receptivity in terms of pinopode expression is not impaired in women with endometriosis in artificially prepared cycles. Fertil Steril 75 (2001) 1231-1233
41. Oborná I., Novotný R., Březinová J., Petrová P., Lichnovský V., and Fingerová H. Changes in the development of uterine pinopodes in steroid hormone supplemented cycles. Physiol Res 53 (2004) 423-429
42. Tourgeman D.E., Gentzchein E., Stanczyk F.Z., and Paulson R.J. Serum and tissue hormone levels of vaginally and orally administered estradiol. Am J Obstet Gynecol 180 (1999) 1480-1483
43. Lewin A., Pisov G., Turgeman R., Fatum M., Shufaro Y., Simon A., et al. Simplified artificial endometrial preparation, using oral estradiol and novel vaginal progesterone tablets: a prospective randomized study. Gynecol Endocrinol 16 (2002) 131-136
44. Dmowski W.P., Michalowska J., Rana N., Friberg J., McGill-Johnson E., and DeOrio L. Subcutaneous estradiol pellets for endometrial preparation in donor oocyte recipients with a poor endometrial response. J Assist Reprod Genet 14 (1997) 139-144
45. Devroey P., Palermo G., Bourgain C., Van Waesberghe L., Smitz J., and Van Steirteghem A.C. Progesterone administration in patients with absent ovaries. Int J Fertil 34 (1989) 188-193
46. Tavaniotou A., Smitz J., Bourgain C., and Devroey P. Comparison between different routes of progesterone administration as luteal phase support in infertility treatments. Hum Reprod Update 6 (2000) 139-148
47. Miles R.A., Paulson R.J., Lobo R.A., Press M.F., Dahmoush L., and Sauer M.V. Pharmacokinetics and endometrial tissue levels of progesterone after administration by intramuscular and vaginal routes: a comparative study. Fertil Steril 62 (1994) 485-490
48. Daya S., and Gunby J. Luteal phase support in assisted reproduction cycles. Cochrane Database Syst Rev 3 (2004) CD004830
49. Manno M., Marchesan E., Cicutto D., Zadro D., Favretti C., and Tomei F. Greater implantation and pregnancy rates with vaginal progesterone in intracytoplasmic sperm injection but not in in vitro fertilization cycles: a retrospective study. Fertil Steril 83 (2005) 1391-1396
50. Lightman A., Kol S., and Itskovitz-Eldor J. A prospective randomized study comparing intramuscular with intravaginal natural progesterone in programmed thaw cycles. Hum Reprod 14 (1999) 2596-2599
51. Gibbons W.E., Toner J.P., Hamacher P., and Kolm P. Experience with a novel vaginal progesterone preparation in a donor oocyte program. Fertil Steril 69 (1998) 96-101
52. Navot D., Anderson T.L., Droesch K., Scott R.T., Kreiner D., and Rosenwaks Z. Hormonal manipulation of endometrial maturation. J Clin Endocrinol Metab 68 (1989) 801-807
53. Simon A., Hurwitz A., Zentner B.S., Bdolah Y., and Laufer N. Transfer of frozen-thawed embryos in artificially prepared cycles with and without prior gonadotrophin-releasing hormone agonist suppression: a prospective randomized study. Hum Reprod 13 (1998) 2712-2717
54. Dal Prato L., Borini A., Cattoli M., Bonu M.A., Sciajno R., and Flamigni C. Endometrial preparation for frozen-thawed embryo transfer with or without pretreatment with gonadotropin-releasing hormone agonist. Fertil Steril 77 (2002) 956-960
55. El-Toukhy T., Taylor A., Khalaf Y., Al-Darazi K., Rowell P., Seed P., et al. Pituitary suppression in ultrasound-monitored frozen embryo replacement cycles. A randomized study. Hum Reprod 19 (2004) 874-879
56. Augood C., Duckitt K., and Templeton A.A. Smoking and female infertility: a systematic review and meta-analysis. Hum Reprod 13 (1998) 1532-1539
57. Jick H., Porter J., and Morrison A.S. Relation between smoking and age of natural menopause. Report from the Boston Collaborative Drug Surveillance Program, Boston University Medical Center. Lancet 309 (1977) 1354-1355
58. Crha I., Hruba D., Fiala J., Ventruba P., Zakova J., and Petrenko M. The outcome of infertility treatment by in-vitro fertilisation in smoking and non-smoking women. Centr Eur J Public Health 9 (2001) 64-68
59. Klonoff-Cohen H., Natarajan L., Marrs R., and Yee B. Effects of female and male smoking on success rates of IVF and gamete intra-Fallopian transfer. Hum Reprod 16 (2001) 1382-1390
60. El-Nemr A., Al-Shawaf T., Sabatini L., Wilson C., Lower A.M., and Grudzinskas J.G. Effect of smoking on ovarian reserve and ovarian stimulation in in-vitro fertilization and embryo transfer. Hum Reprod 13 (1998) 2192-2198
61. Shiverick K.T., and Salafia C. Cigarette smoking and pregnancy I: ovarian, uterine and placental effects. Placenta 20 (1999) 265-272
62. Neal M.S., Hughes E.G., Holloway A.C., and Foster W.G. Sidestream smoking is equally as damaging as mainstream smoking on IVF outcomes. Hum Reprod 20 (2005) 2531-2535
63. Pattinson H.A., Taylor P.J., and Pattinson M.H. The effect of cigarette smoking on ovarian function and early pregnancy outcome of in vitro fertilization treatment. Fertil Steril 55 (1991) 780-783
64. Klonoff-Cohen H. Female and male lifestyle habits and IVF: what is known and unknown. Hum Reprod Update 11 (2005) 179-203
65. Soares S.R., Simón C., Remohí S.R., and Pellicer A. Cigarette smoking affects uterine receptiveness. Hum Reprod 22 (2007) 543-547
66. Parazzini F., Chatenoud L., Benzi G., Dal Cintio E., Dal Pino D., Tozzi L., et al. Coffee and alcohol intake, smoking and the risk of multiple pregnancy. Hum Reprod 11 (1996) 2306-2309
67. Olsen J., Bonnelykke B., and Nielsen J. Tobacco smoking and twinning. Acta Med Scand 224 (1998) 491-494
68. Camus E., Poncelet C., Goffinet F., Wainer B., Merlet F., Nisand I., and Philippe H.J. Pregnancy rates after in-vitro fertilization in cases of tubal infertility with and without hydrosalpinx: a meta-analysis of published comparative studies. Hum Reprod 14 (1999) 1243-1249
69. Andersen A.N., Yue Z., Meng F.J., and Petersen K. Low implantation rates after in-vitro fertilization in patients with hydrosalpinges diagnosed by ultrasonography. Hum Reprod 9 (1994) 1935-1938
70. Strandell A., Lindhard A., Waldenström U., Thoburn J., Janson P.O., and Hamberger L. Hydrosalpinx and IVF outcome: a prospective, randomized multicentre trial in Scandinavia on salpingectomy prior to IVF. Hum Reprod 14 (1999) 2762-2769
71. Strandell A., Sjögren A., Bentin-Ley U., Thorburn J., Hamberger L., and Brännström M. Hydrosalpinx fluid does not adversely affect the normal development of human embryos and implantation in vitro. Hum Reprod 3 (1998) 2921-2925
72. Meyer W.R., Castelbaum A.J., Somkuti S., Sagoskin A.W., Doyle M., Harris J.E., et al. Hydrosalpinges adversely affect markers of endometrial receptivity. Hum Reprod 12 (1997) 1393-1398
73. Bildirici I., Bukulmez O., Ensari A., Yarali H., and Gurgan T. A prospective evaluation of the effect of salpingectomy on endometrial receptivity in cases of women with communicating hydrosalpinges. Hum Reprod 16 (2001) 2422-2426
74. Seli E., Kayisli U.A., Cakmak H., Bukulmez O., Bildirici I., Guzeloglu-Kayisli O., et al. Removal of hydrosalpinges increases endometrial leukaemia inhibitory factor (LIF) expression at the time of the implantation window. Hum Reprod 20 (2005) 3012-3017
75. Johnson N.P., Mak W., and Sowter M.C. Surgical treatment for tubal disease in women due to undergo in vitro fertilization. Cochrane Database Syst Rev 3 (2004) CD002125
76. Stadtmauer L.A., Riehl R.M., Toma S.K., and Talbert L.M. Cauterization of hydrosalpinges before in vitro fertilization is an effective surgical treatment associated with improved pregnancy rates. Am J Obstet Gynecol 183 (2000) 367-371
77. Hurst B.S., Tucker K.E., Awoniyi C.A., and Schlaff W.D. Hydrosalpinx treated with extended doxycycline does not compromise the success of in vitro fertilization. Fertil Steril 75 (2001) 1017-1019
78. Barnhart K., Dunsmoor-Su R., and Coutifaris C. Effect of endometriosis on in vitro fertilization. Fertil Steril 77 (2002) 1148-1155
79. Kuivasaari P., Hippeläinen M., Anttila M., and Heinonen S. Effect of endometriosis on IVF/ICSI outcome: stage III/IV endometriosis worsens cumulative pregnancy and live-born rates. Hum Reprod 20 (2005) 3130-3135
80. Sharpe-Timms K., Keisler L.W., McIntush E.W., and Keisler D.H. Tissue inhibitor of metalloproteinase-1 concentrations are attenuated in peritoneal fluid and sera of women with endometriosis and restored in sera by gonadotropin-releasing hormone agonist therapy. Fertil Steril 69 (1998) 1128-1134
81. Taketani Y., Kuo T.M., and Mizuno M. Comparison of cytokine levels and embryo toxicity in peritoneal fluid in infertile women with untreated or treated endometriosis. Am J Obstet Gynecol 167 (1992) 265-270
82. Ulukus M., and Arici A. Immunology of endometriosis. Minerva Ginecol 57 (2005) 237-248
83. Cunha-Filho J.S., Gross J.L., Bastos de Souza C.A., Lemos N.A., Giuliano C., Freitas F., et al. Physiopathological aspects of corpus luteum defect in infertile patients with mild/minimal endometriosis. J Assist Reprod Genet 20 (2003) 117-121
84. Ayers J.W., Birenbaum D.L., and Menon K.M. Luteal phase dysfunction in endometriosis: elevated progesterone levels in peripheral and ovarian veins during the follicular phase. Fertil Steril 47 (1987) 925-929
85. Simón C., Gutiérrez A., Vidal A., de los Santos M.J., Tarín J.J., Remohí J., et al. Outcome of patients with endometriosis in assisted reproduction: results from in-vitro fertilization and oocyte donation. Hum Reprod 9 (1994) 725-729
86. Sung L., Mukherjee T., Takeshige T., Bustillo M., and Copperman A. Endometriosis is not detrimental to embryo implantation in oocyte recipients. J Assist Reprod Genet 14 (1997) 152-156
87. Díaz I., Navarro J., Blasco L., Simón C., Pellicer A., and Remohí J. Impact of stage III-IV endometriosis on recipients of sibling oocytes: matched case-control study. Fertil Steril 74 (2000) 31-34
88. Imai A., Takagi A., and Tamaya T. Gonadotropin-releasing hormone analog repairs reduced endometrial cell apoptosis in endometriosis in vitro. Am J Obstet Gynecol 182 (2000) 1142-1146
89. Surrey E.S., Silverberg K.M., Surrey M., and Schoolcraft W.B. Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis. Fertil Steril 78 (2002) 699-704
90. Sallam H., Garcia-Velasco J., Dias S., and Arici A. Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane Database Syst Rev 25 1 (2006) CD004635
91. Bergholt T., Eriksen L., Berendt N., Jacobsen M., and Hertz J.B. Prevalence and risk factors of adenomyosis at hysterectomy. Hum Reprod 16 (2001) 2418-2421
92. Vercellini P., Cortesi I., de Giorgi O., Merlo D., Carinelli S.G., and Crosignani P.G. Transvaginal ultrasonography versus uterine needle biopsy in the diagnosis of diffuse adenomyosis. Hum Reprod 13 (1998) 2884-2887
93. Bazot M., Cortez A., Darai E., Rouger J., Chopier J., Antoine J.-M., et al. Ultrasonography compared with magnetic resonance imaging for the diagnosis of adenomyosis: correlation with histopathology. Hum Reprod 16 (2001) 2427-2433
94. Dueholm M., Lundorf E., Hansen E.S., Sørensen J.S., Ledertoug S., and Olesen F. Magnetic resonance imaging and transvaginal ultrasonography for the diagnosis of adenomyosis. Fertil Steril 76 (2001) 588-594
95. Giana M., Montella F., Surico D., Vigone A., Bozzola C., and Ruspa G. Large intramyometrial cystic adenomyosis: a hysteroscopic approach with bipolar resectoscope: case report. Eur J Gynaecol Oncol 26 (2005) 462-463
96. Keckstein J. Hysteroscopy and adenomyosis. Contrib Gynecol Obstet 20 (2000) 41-50
97. Imaoka I., Wada A., Matsuo M., Yoshida M., Kitagaki H., and Sugimura K. MR imaging of disorders associated with female infertility: use in diagnosis, treatment, and management. Radiographics 23 (2003) 1401-1421
98. Dueholm M., Lundorf E., Sorensen J.S., Ledertoug S., Olesen F., and Laursen H. Reproducibility of evaluation of the uterus by transvaginal sonography, hysterosonographic examination, hysteroscopy and magnetic resonance imaging. Hum Reprod 17 (2002) 195-200
99. Kunz G., and Leyendecker G. Uterine peristaltic activity during the menstrual cycle: characterization, regulation, function and dysfunction. Reprod Biomed Online 4 Suppl 3 (2002) 5-9
100. Hickey M., and Fraser I. Human uterine vascular structures in normal and diseased states. Microsc Res Tech 60 (2003) 377-389
101. Ota H., and Tanaka T. Stromal vascularization in the endometrium during adenomyosis. Microsc Res Tech 60 (2003) 445-449
102. Van Voorhis B.J., Huettner P.C., Ckark M.R., and Hill J.A. Immunohistochemical localization of prostaglandin H synthase in the female reproductive tract and endometriosis. Am J Obstet Gynecol 163 (1990) 57-62
103. Kitawaki J., Noguchi T., Amatsu T., Maeda K., Tsukamoto K., Yamamoto T., et al. Expression of aromatase cytochrome P450 protein and messenger ribonucleic acid in human endometriotic and adenomyotic tissues but not in normal endometrium. Biol Reprod 57 (1997) 514-519
104. Brosens J., Verhoeven H., Campo R., Gianaroli L., Gordts S., Hazekamp J., et al. High endometrial aromatase P450 mRNA expression is associated with poor IVF outcome. Hum Reprod 19 (2004) 352-356
105. Hishihara H., Kitawaki J., Kado N., Koshiba H., Fushiki S., and Honjo H. Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas. Fertil Steril 79 Suppl 1 (2003) 735-742